Experience in stapedotomy at the Hospital Universitario Clínica San Rafael between 2018 - 2019

Autor: Socha, Monica

El manejo quirúrgico de la fijación del estribo es el tratamiento preferido para la pérdida auditiva conductiva en otosclerosis. (1) Posterior al procedimiento quirúrgico, es importante evaluar la efectividad de la cirugía, una forma de realizar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2802::481429a7429034c2b8c351a274b8524b
https://hdl.handle.net/10654/41515

Análisis del programa de detección precoz de hipoacusia en recién nacidos en la provincia de Salamanca (años 2005-2014)

Autor: Hortensia Sánchez Gómez

Publikováno v: GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname

[ES] La hipoacusia es un problema de Salud Pública y sus consecuencias en los niños se ponen de manifiesto cuando ésta se desarrolla en el periodo neonatal. Se trata de una enfermedad que cumple con todos los requisitos para ser sometida a un crib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831e7ce4b1cc905fb326537fc19191be
https://doi.org/10.14201/gredos.140346

Diferencia en calidad de vida en pacientes con rinitis alérgica con beclometasona vs furoato de mometasona y fluticasona

Autor: Reyes Gelves, Camilo, Ballesteros Rodríguez, Lilian

Publikováno v: Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8–160. doi:10.1111/j.1398-9995.2007.01620.x.
Dennis RJ, Caraballo L, García E, et al. Prevalence of asthma and other allergic conditions in Colombia 2009-2010: a cross-sectional study. BMC Pulm Med. 2012;12:17. doi:10.1186/1471-2466-12-17.
Mygind N, Andersson M. Topical glucocorticosteroids in rhinitis: clinical aspects. Acta Otolaryngol. 2006;126(10):1022–1029. doi:10.1080/00016480600672550.
Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am. 2009;29(4):657–668. doi:10.1016/j.iac.2009.07.001.
Aït-Khaled N, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123–148. doi:10.1111/j.1398-9995.2008.01884.x.
Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–47. doi:10.1016/j.jaci.2004.04.042
Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1–84. doi:10.1016/j.jaci.2008.06.003.
Valero A, Baró E, Sastre J, et al. Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version). J Investig Allergol Clin Immunol. 2009;19(5):396–403.
Martínez C, Sossa M, Lemos E. Cost-Effectiveness Analysis of Mometasone Furoate Versus Beclomethasone Dipropionate for the Treatment of Pediatric Allergic Rhinitis in Colombia. Adv Ther 2015; 32:254–269.
Berger W, Meltzer E. Intranasal spray medications for maintenance therapy of allergic rhinitis. Am J Rhinol Allergy 2015; 29: 273-282.
Berlucchi M, Pedruzzi B. Intranasal Mometasone Furoate for Treatment of Allergic Rhinitis. Clinical Medicine Insights: Therapeutics 2010:2 761–769
Yonezaki M, Akiyama K, Karaki M, Goto R, et. all. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis. Auris Nasus Larynx 2015.
Penagos M, Compalati M, Tarantini F, et.all. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 2008: 63: 1280–1291.
Meltzer E, Jacobs E, LaForce C, Kelle L, et.all. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc 2012; 33:249 –257.
Farid R, Farid F, Ghaffari J, Jabbarri F. Evaluation of fluticasone nasal spray vs Beclometasona nasal spray in the treatment of allergic rhinitis. Iranian journal of allergy, asthma and inmunology. 2003; 2: 193-196.
Jaruvongvanich V, Mongkolpathumrat P, Chantaphakul H, Klaewsongkram J. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life. 2015; 1-5.
Blaiss MS, Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergic asma proc. 2011 Nov-Dec;32(6):413-8.
Berger, W; Jacobs R; Amar N ; Sudeesh K, et all. Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis. Ann Allergy Asthma Immunol 115 (2015) 130-136.
Crawford1 B, Stanford R, Wong A, Dalal A, Bayliss M. Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire. Patient Related Outcome Measures 2011:2 127–133
Piotr K; Wojciech; J, Spencer K, Katarina Z. Comparative safety and efficacy of two formulations of mometasone nasal spray in adult seasonal allergic rhinitis. Allergy and asthma procedingns 2014, Volume 35, Number 4: 332-337(6)
Davies R, Nelson H. Once-Daily Mometasone Furoate Nasal Spray: Efficacy and Safety of a New Intranasal Glucocorticoid for Allergic Rhinitis. Clinical therapeutics. 1997; 19: 27-38
Hebert JR, Nolop K, Lutsky B. Once daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active-and placebo-controlled study. Allergy. 1996;51:569-576
Drouin M, Yang WH, Bertrand B, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for perennial allergic rhinitis patients. Ann Allergy Asthma Zmmunol. 1996:77:153-160.
Sharpe M, Jarvis B. Inhaled mometasone furoate: A review of its use in adults and adolescents with persistent asthma [published correction appears in Drugs. 2001;61:1325– 1350
Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium. Drug Saf. 2000;23:11–33.
Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther. 1997;19:27–38; discussion 2–3.
Frieri M, Therattil J, Chavarria V, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1998;81:431–437.
Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy. 2002;22:1458– 1467.
Gawchik S, Goldstein S, Prenner B, John A. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol. 2003;90:416–421.
Austin RJ, Maschera B, Walker A, et al. Mometasone furoate is a less specific glucocorticoid than fluticasone propionate. Eur Respir J. 2002; 20:1386–1392.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Introducción: La rinitis alérgica es una condición común en gran parte de la población en general. Afecta aproximadamente al 32% de la población en general. Materiales y métodos: Estudio prospectivo en cohorte con un diagnóstico clínico de r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eedd1cec49d34c59de2c86c64d77d21
http://repository.urosario.edu.co/handle/10336/12924

Updating the treatment of recurrent tonsillitis in adults. Review

Autor: María Cristina GASCÓN-RUBIO, Albino José ALONSO-ALONSO

Publikováno v: GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
Revista ORL, Vol 7, Iss 1, Pp 23-34 (2016)

Introduction and Objectives: Acute pharyngitis in adults (APA) is one of the most frequent reasons for consultation in primary care. The main objective of this review is to update the therapeutic options for the prevention and treatment of APA and to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b624d17d523d55fa96618f4820cc1b61
https://hdl.handle.net/10366/128204

Otolaryngologic disease in children from charity homes

Autor: Correa U, Aliro, Silinas II, Virginia

Publikováno v: Revista chilena de pediatría, Volume: 58, Issue: 1, Pages: 77-79, Published: FEB 1987

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______614::50280abadffd1a78c4c8e65f0fe9d347
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370-41061987000100014&lng=en&tlng=en